Haring-Layton MarDee bought DARE

September 4, 2025 · Form 4 insider transaction

Haring-Layton MarDee bought 57,000 shares of Daré Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
57,000
Price
$0.00
Total value
N/A
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 4, 2025
Filing dateSeptember 4, 2025
Shares owned after57,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer.

View the original Form 4 on SEC EDGAR